PERRONE, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 2.106
EU - Europa 1.858
AS - Asia 818
SA - Sud America 77
AF - Africa 17
OC - Oceania 12
Totale 4.888
Nazione #
US - Stati Uniti d'America 2.081
PL - Polonia 781
RU - Federazione Russa 526
SG - Singapore 271
CN - Cina 190
IT - Italia 170
HK - Hong Kong 165
IE - Irlanda 98
SE - Svezia 88
DE - Germania 64
BR - Brasile 62
KR - Corea 59
VN - Vietnam 32
JO - Giordania 27
FI - Finlandia 26
GB - Regno Unito 26
IN - India 22
CH - Svizzera 15
ES - Italia 14
FR - Francia 14
CA - Canada 13
ID - Indonesia 11
AU - Australia 10
AR - Argentina 9
AT - Austria 9
ZA - Sudafrica 9
JP - Giappone 8
NL - Olanda 7
BD - Bangladesh 6
IQ - Iraq 6
MX - Messico 6
TR - Turchia 6
UA - Ucraina 5
BE - Belgio 4
CI - Costa d'Avorio 4
MA - Marocco 3
SA - Arabia Saudita 3
BG - Bulgaria 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
JM - Giamaica 2
NZ - Nuova Zelanda 2
PH - Filippine 2
UZ - Uzbekistan 2
VE - Venezuela 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
LT - Lituania 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 4.888
Città #
Warsaw 776
Santa Clara 473
Ashburn 244
Singapore 171
Fairfield 154
Hong Kong 139
Chandler 129
Dublin 98
Beijing 81
Houston 81
Cambridge 79
Seattle 79
Woodbridge 70
Wilmington 60
Seoul 58
Ann Arbor 44
Florence 44
Altamura 36
Buffalo 35
Lawrence 32
The Dalles 29
New York 27
Princeton 27
Los Angeles 26
San Jose 26
Bremen 23
Boston 20
Dallas 20
Munich 19
Shanghai 18
Boardman 16
Medford 15
Mumbai 15
Bern 14
Hefei 14
Clifton 13
Kent 13
Paris 13
Moscow 11
Melbourne 10
Phoenix 10
San Diego 10
Barcelona 9
Jakarta 9
Dong Ket 8
Helsinki 8
Johannesburg 8
Norwich 8
Redondo Beach 8
Ho Chi Minh City 7
Toronto 7
Vienna 7
Jacksonville 6
London 6
Tokyo 6
Chicago 5
Hanoi 5
Norwalk 5
Orem 5
Stockholm 5
São Paulo 5
Abidjan 4
Brooklyn 4
Cagliari 4
Council Bluffs 4
Dearborn 4
Falls Church 4
Guangzhou 4
Lappeenranta 4
Milan 4
Brasília 3
Brussels 3
Latina 3
Mexico City 3
Newark 3
Rome 3
San Francisco 3
Sinalunga 3
Tianjin 3
Turin 3
Turku 3
Vancouver 3
Amsterdam 2
Athens 2
Baghdad 2
Belo Horizonte 2
Blumenau 2
Bologna 2
Copenhagen 2
Cotia 2
Dhaka 2
Haiphong 2
Hillsboro 2
Itanhaém 2
Meppel 2
Montego Bay 2
Montreal 2
North Bergen 2
Padova 2
Perugia 2
Totale 3.507
Nome #
RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 329
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 299
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 290
Druggable Targets in Pancreatic Adenocarcinoma 283
Identificazione di MTHFR 1298A>C come marcatore predittivo di sopravvivenza in due coorti di pazienti con carcinoma colorettale (stadio II e III) trattati con chemioterapia adiuvante a base di fluoropirimidine con o senza oxaliplatino 279
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 252
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 226
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 215
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 205
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 188
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 187
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 182
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 174
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 171
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 170
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 168
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 166
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 157
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 151
Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience 144
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 137
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 135
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 128
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 113
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 108
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients 87
Totale 4.944
Categoria #
all - tutte 12.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 0 35 21 36 48 20 22
2021/2022178 6 6 7 6 3 17 4 21 12 14 26 56
2022/2023576 47 116 34 57 36 86 59 28 69 1 12 31
2023/2024248 4 21 30 10 11 27 27 72 6 7 15 18
2024/20251.399 56 128 89 236 396 190 19 90 64 41 46 44
2025/2026926 191 179 79 126 232 77 42 0 0 0 0 0
Totale 4.944